Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis

By C. Lukas, R. Landewé, J. Sieper, M. Dougados, John A. Davis, J. Braun, S. V. D. Linden, D. Heijde. 2008

975 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Interval Coded Scoring: a toolbox for interpretable scoring systems (2018, background): “…scoring systems include Alvarado for appendicitis (Alvarado, 1986), CHA 2 DS 2 -VASc for atrial ﬁbrillation (Lip et al., 2010), Glasgow for pancreatitis (Mounzer et al., 2012), CURB-65 for pneumonia (Jeong et al., 2013) and ASDAS for disease activity in ankylosing spondylitis (Lukas et al., 2009).”
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis (2017, background): “55 87 Another argument is that increased ASDAS may lead to syndesmophyte formation, while this has not been proven for BASDAI alone (BASDAI works only if combined with CRP).”
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update (2022, positive): “[25,35,36,40,90-92] When it is not possible to use the ASDAS, it is better to use the BASDAI than no instrument at all, but we advocate that all efforts are made to implement the ASDAS in daily clinical practice.”